Cuorips Inc. [4894.T]

TOKYO, May 26 (Pulse News Wire) – Cuorips Inc. (4894.T) announced changes to its board of directors effective June 25, 2026.

The decisions were made during a board meeting held , and will be formally ratified at the upcoming annual shareholders' meeting scheduled for June 25, 2026. Current directors reaffirmed for their roles include Chairman and CEO Kusaba Takayuki, Vice President Tamura Tadayuki, Chief Technology Officer Sawaguchi Yoshiaki, and Chief Medical Science Officer Hirao Kazuyoshi. Additionally, external director Yoshida Kenichiro will continue his role. New appointee Kato Nozomi will join the board.

Kato Nozomi, born April 1984, brings extensive experience from Denso Corporation, serving in various leadership positions including Deputy Director of IC Technology Division, Executive Director of Device Business Unit, Information Communication Business Unit, and Mobility Systems Group Leader. He currently serves as President of Yukiyaku ConCon and external director of Nippon Process Co., Ltd. and Nihon Shoji Co., Ltd. Retiring due to term expiration is external director Sakushima Masaru, who will step down upon conclusion of the shareholders' meeting.

Following the annual meeting, the revised board structure will consist of: Chairman and CEO: Kusaba Takayuki Vice President: Tamura Tadayuki Chief Technology Officer: Sawaguchi Yoshiaki Chief Medical Science Officer: Hirao Kazuyoshi External Directors: Yoshida Kenichiro and Kato Nozomi Independent Auditors: Arata Norihisa, Yamamoto Koutarou, and Abe Shinji.

Original Disclosure (PDF)

🟡 Confidence: Standard AI-translated content.